Plain-English translation of NCT07599969 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study is developing a tool called the Bronchiectasis Phenotype Identification Model (BPIM) to help doctors identify different subtypes of non-cystic fibrosis bronchiectasis โ a chronic lung condition where airways become damaged and inflamed. Researchers will collect health information from adults with this condition over time to understand how the disease progresses differently in different people, then create a simple test that doctors can use at a patient's first visit to figure out which subtype they have.
Patients with non-cystic fibrosis bronchiectasis often have very different disease patterns and outcomes, but doctors currently don't have a good way to identify these different subtypes at the start of treatment. This study aims to create a practical tool that can recognize these patterns early, which could help doctors predict how the disease will progress and plan better care.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will be enrolled in either a development group or a validation group. Both groups will have baseline medical assessments including lung function tests, CT imaging review, blood work, and oxygen level measurements. You will then be asked to attend follow-up appointments so researchers can track how your condition changes over time. The study does not assign any specific treatment or medication โ your regular care continues as usual while you share your health information with the research team.
AI-generated summary from trial data ยท Jun 3, 2026 ยท Not medical advice
Egypt